Cargando…

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer

Epithelial-mesenchymal transition (EMT) is a cellular reprogramming process that converts epithelial cells into mesenchymal-like cells with migratory and invasive capabilities. The initiation and regulation of EMT is closely linked to a range of transcription factors, cell adhesion molecules and sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Wenrong, Zhou, Zubang, Shao, Liping, Wang, Qi, Feng, Wanxue, Tang, Yuling, He, Yizong, Wang, Yuanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661308/
https://www.ncbi.nlm.nih.gov/pubmed/38023171
http://dx.doi.org/10.3389/fonc.2023.1257985
_version_ 1785137946355040256
author Mu, Wenrong
Zhou, Zubang
Shao, Liping
Wang, Qi
Feng, Wanxue
Tang, Yuling
He, Yizong
Wang, Yuanlin
author_facet Mu, Wenrong
Zhou, Zubang
Shao, Liping
Wang, Qi
Feng, Wanxue
Tang, Yuling
He, Yizong
Wang, Yuanlin
author_sort Mu, Wenrong
collection PubMed
description Epithelial-mesenchymal transition (EMT) is a cellular reprogramming process that converts epithelial cells into mesenchymal-like cells with migratory and invasive capabilities. The initiation and regulation of EMT is closely linked to a range of transcription factors, cell adhesion molecules and signaling pathways, which play a key role in cancer metastasis and drug resistance. The regulation of ferroptosis is intricately linked to various cell death pathways, intracellular iron homeostasis, and the protein network governing iron supply and storage. The ability of ferroptosis to disrupt cancer cells and overcome drug resistance lies in its control of intracellular iron ion levels. EMT process can promote the accumulation of iron ions, providing conditions for ferroptosis. Conversely, ferroptosis may impact the regulatory network of EMT by modulating transcription factors, signaling pathways, and cell adhesion molecules. Thus, ferroptosis related genes and signaling pathways and oxidative homeostasis play important roles in the regulation of EMT. In this paper, we review the role of ferroptosis related genes and their signaling pathways in regulating cancer EMT to better understand the crosstalk mechanism between ferroptosis and EMT, aiming to provide better therapeutic strategies for eradicating cancer cells and overcoming drug resistance.
format Online
Article
Text
id pubmed-10661308
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106613082023-01-01 Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer Mu, Wenrong Zhou, Zubang Shao, Liping Wang, Qi Feng, Wanxue Tang, Yuling He, Yizong Wang, Yuanlin Front Oncol Oncology Epithelial-mesenchymal transition (EMT) is a cellular reprogramming process that converts epithelial cells into mesenchymal-like cells with migratory and invasive capabilities. The initiation and regulation of EMT is closely linked to a range of transcription factors, cell adhesion molecules and signaling pathways, which play a key role in cancer metastasis and drug resistance. The regulation of ferroptosis is intricately linked to various cell death pathways, intracellular iron homeostasis, and the protein network governing iron supply and storage. The ability of ferroptosis to disrupt cancer cells and overcome drug resistance lies in its control of intracellular iron ion levels. EMT process can promote the accumulation of iron ions, providing conditions for ferroptosis. Conversely, ferroptosis may impact the regulatory network of EMT by modulating transcription factors, signaling pathways, and cell adhesion molecules. Thus, ferroptosis related genes and signaling pathways and oxidative homeostasis play important roles in the regulation of EMT. In this paper, we review the role of ferroptosis related genes and their signaling pathways in regulating cancer EMT to better understand the crosstalk mechanism between ferroptosis and EMT, aiming to provide better therapeutic strategies for eradicating cancer cells and overcoming drug resistance. Frontiers Media S.A. 2023-11-07 /pmc/articles/PMC10661308/ /pubmed/38023171 http://dx.doi.org/10.3389/fonc.2023.1257985 Text en Copyright © 2023 Mu, Zhou, Shao, Wang, Feng, Tang, He and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Mu, Wenrong
Zhou, Zubang
Shao, Liping
Wang, Qi
Feng, Wanxue
Tang, Yuling
He, Yizong
Wang, Yuanlin
Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
title Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
title_full Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
title_fullStr Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
title_full_unstemmed Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
title_short Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
title_sort advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661308/
https://www.ncbi.nlm.nih.gov/pubmed/38023171
http://dx.doi.org/10.3389/fonc.2023.1257985
work_keys_str_mv AT muwenrong advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT zhouzubang advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT shaoliping advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT wangqi advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT fengwanxue advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT tangyuling advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT heyizong advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer
AT wangyuanlin advancesintherelationshipbetweenferroptosisandepithelialmesenchymaltransitionincancer